Pulmonary Tumor Thrombotic Microangiopathy With Biventricular Heart Failure. [PDF]
Mihara Y +8 more
europepmc +1 more source
Safety and efficacy of eculizumab in pediatric patients with aHUS, with or without baseline dialysis [PDF]
Bedrosian, Camille L +5 more
core +1 more source
Eculizumab in treatment for complement-mediated thrombotic microangiopathy associated with acute pancreatitis. [PDF]
Shettigar S +3 more
europepmc +1 more source
Reply: Belatacept as an Emerging Option in Immunosuppression-Induced Thrombotic Microangiopathy After Heart Transplantation. [PDF]
Massad F, Agdamag AC.
europepmc +1 more source
Complement activation in thrombotic thrombocytopenic purpura [PDF]
Alvarez-Larran +28 more
core +1 more source
Thrombotic microangiopathy in a patient with COVID-19
K. Jhaveri +7 more
semanticscholar +1 more source
Efficacy of Plasma Exchange in Secondary Thrombotic Microangiopathy: A Case Report and Literature Review. [PDF]
Fukunaga S, Masuda N, Tanno Y, Yokoo T.
europepmc +1 more source
Pulmonary Tumor Thrombotic Microangiopathy in Platinum-Resistant Ovarian Cancer - A Case Report. [PDF]
Lim SS, Wong SW.
europepmc +1 more source
Chemotherapy-Induced Thrombotic Microangiopathy in a Pediatric Patient With a Single Functioning Kidney: A Case Report and Review of the Literature. [PDF]
Jamil M, Khan BSA, Rashid A, Shaheen N.
europepmc +1 more source
Use of narsoplimab for eculizumab-refractory adult transplant-associated thrombotic microangiopathy (TA-TMA). [PDF]
Young S, Varadarajan I.
europepmc +1 more source

